Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRK

Merck

$63.75

0.24 (0.38%)

, GSK

GlaxoSmithKline

$41.10

0.09 (0.22%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
European Society of Gene & Cell Therapy will hold a conference »

25th Anniversary Congress…

MRK

Merck

$63.75

0.24 (0.38%)

GSK

GlaxoSmithKline

$41.10

0.09 (0.22%)

TECH

Bio-Techne

$123.46

0.33 (0.27%)

PLL

Pall Corp.

ICEL

Cellular Dynamics

ABEO

Abeona Therapeutics

$17.75

0.25 (1.43%)

KITE

Acquired by GILD 9/17

PFE

Pfizer

$36.24

0.41 (1.14%)

BMRN

BioMarin

$88.13

-0.49 (-0.55%)

SHPG

Shire

$147.82

1.53 (1.05%)

TIG

TiGenix

$24.21

0.91 (3.91%)

BIIB

Biogen

$342.42

-2.16 (-0.63%)

QURE

uniQure

$15.16

5.69 (60.08%)

SGMO

Sangamo

$13.95

-0.2 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 02

    Feb

  • 28

    Feb

  • 17

    Oct

Yesterday
BMRN

BioMarin

$88.62

-4.92 (-5.26%)

09:37
10/19/17
10/19
09:37
10/19/17
09:37
Recommendations
BioMarin analyst commentary at Credit Suisse »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

VZ

Verizon

, DHR

Danaher

09:28
10/19/17
10/19
09:28
10/19/17
09:28
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

VZ

Verizon

DHR

Danaher

BX

Blackstone

DGX

Quest Diagnostics

LLNW

Limelight Networks

$4.48

0.12 (2.75%)

URI

United Rentals

GILD

Gilead

$80.01

-0.23 (-0.29%)

BLFS

BioLife Solutions

$6.10

0.33 (5.72%)

ONCE

Spark Therapeutics

$82.00

-0.97 (-1.17%)

CRBP

Corbus Pharmaceuticals

$7.00

-0.05 (-0.71%)

PM

Philip Morris

BBT

BB&T

BK

BNY Mellon

DOV

Dover

EBAY

eBay

$37.97

0.48 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 26

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 12

    Jan

  • 12

    Feb

BMRN

BioMarin

$88.62

-4.92 (-5.26%)

09:26
10/19/17
10/19
09:26
10/19/17
09:26
Recommendations
BioMarin analyst commentary at Leerink »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

MRK

Merck

$63.51

0.29 (0.46%)

, GSK

GlaxoSmithKline

$41.01

0.18 (0.44%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
European Society of Gene & Cell Therapy will hold a conference »

25th Anniversary Congress…

MRK

Merck

$63.51

0.29 (0.46%)

GSK

GlaxoSmithKline

$41.01

0.18 (0.44%)

TECH

Bio-Techne

$123.13

-0.21 (-0.17%)

PLL

Pall Corp.

ICEL

Cellular Dynamics

ABEO

Abeona Therapeutics

$17.50

-0.4 (-2.23%)

KITE

Acquired by GILD 9/17

PFE

Pfizer

$35.83

-0.37 (-1.02%)

BMRN

BioMarin

$88.62

-4.92 (-5.26%)

SHPG

Shire

$146.29

-5.76 (-3.79%)

TIG

TiGenix

$23.30

-0.79 (-3.28%)

BIIB

Biogen

$344.58

0.11 (0.03%)

QURE

uniQure

$9.47

-2.2 (-18.85%)

SGMO

Sangamo

$14.15

-0.35 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 02

    Feb

  • 28

    Feb

  • 17

    Oct

Wednesday
BMRN

BioMarin

$93.54

-1.12 (-1.18%)

15:33
10/18/17
10/18
15:33
10/18/17
15:33
Recommendations
BioMarin analyst commentary at Piper Jaffray »

Piper says BioMarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:34
10/18/17
10/18
12:34
10/18/17
12:34
Hot Stocks
BioMarin says Pegvaliase application remains on track »

BioMarin said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:32
10/18/17
10/18
12:32
10/18/17
12:32
Hot Stocks
BioMarin provides update on development portfolio »

BioMarin updated the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:29
10/18/17
10/18
12:29
10/18/17
12:29
Earnings
BioMarin sees 2017 product revenue at mid-point of guidance »

BioMarin said that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

ABUS

Arbutus Biopharma

$6.95

-0.3 (-4.14%)

08:14
10/18/17
10/18
08:14
10/18/17
08:14
Hot Stocks
Arbutus Biopharma and Gritstone Oncology announce LNP technology agreement »

Arbutus Biopharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.